---
title: "Autek China Inc. (300595.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300595.SZ.md"
symbol: "300595.SZ"
name: "Autek China Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T22:42:51.994Z"
locales:
  - [en](https://longbridge.com/en/quote/300595.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300595.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300595.SZ.md)
---

# Autek China Inc. (300595.SZ)

## Company Overview

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.orthok.cn](https://www.orthok.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.41)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 17 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.83% |  |
| Net Profit YoY | -13.74% |  |
| P/B Ratio | 2.33 |  |
| Dividend Ratio | 1.43% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 11820899207.26 |  |
| Revenue | 1845660094.87 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.39% | B |
| Profit Margin | 25.26% | A |
| Gross Margin | 71.61% | A |
| Revenue YoY | 0.83% | C |
| Net Profit YoY | -13.74% | D |
| Total Assets YoY | 1.99% | C |
| Net Assets YoY | 3.44% | C |
| Cash Flow Margin | 146.37% | B |
| OCF YoY | 0.83% | C |
| Turnover | 0.29 | D |
| Gearing Ratio | 13.63% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Autek China Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.83%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-13.74%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.33",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.43%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "11820899207.26",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1845660094.87",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.39%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "25.26%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "71.61%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "0.83%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-13.74%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.99%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.44%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "146.37%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "0.83%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.29",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "13.63%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 24.83 | 9/40 | 30.35 | 28.48 | 25.99 |
| PB | 2.28 | 21/40 | 3.20 | 2.86 | 2.70 |
| PS (TTM) | 6.27 | 22/40 | 8.48 | 7.72 | 7.29 |
| Dividend Yield | 1.46% | 17/40 | 1.87% | 1.68% | 1.31% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-27T16:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 2 | 50% |
| Underweight | 1 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 12.91 |
| Highest Target | 18.10 |
| Lowest Target | 13.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300595.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300595.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300595.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300595.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**